1). Anderson EJ., Weber SG. Rotavirus infection in adults. Lancet Infect Dis. 2004. 4:91–9.
Article
2). Kapikian AZ. Viral gastroenteritis. JAMA. 1993. 269:627–30.
Article
3). Moon HH., Kim DS., Park SH., Kim H. Clinical characteristics and genotype of rotavirus infection in newborn infants. Korean J Perinatol. 2012. 23:266–72.
4). Sugata K., Taniguchi K., Yui A., Miyake F., Suga S., Asano Y, et al. Analysis of rotavirus antigenemia and extraintestinal manifestations in children with rotavirus gastroenteritis. Pediatrics. 2008. 122:392–7.
Article
5). Kim DK., Jeong DS., Kim CR., Oh SH., Moon SJ. Clinical and epidemiologic features of rotavirus outbreak in a nursery. J Korean Soc Neonatol. 2003. 10:208–17.
6). Rodriguez WJ., Kim HW., Brandt CD., Schwartz RH., Gardner MK., Jeffries B, et al. Longitudinal study of rotavirus infection and gastroenteritis in families served by a pediatric medical practice: clinical and epidemiologic observations. Pediatr Infect Dis J. 1987. 6:170–6.
7). de Villiers FP., Steele AD., Driessen M. Central nervous system involvement in neonatal rotavirus infection. Ann Trop Paediatr. 2003. 23:309–12.
Article
8). Saulsbury FT., Winkelstein JA., Yolken RH. Chronic rotavirus infection in immunodeficiency. J Pediatr. 1980. 97:61–5.
Article
9). Sızmaz E., Satar M., Ozlü F., Yaman A., Yıldızdaş HY., Ozcan K. The coincidence of necrotizing enterocolitis and rotavirus infections and potential associations with cytokines. Can J Infect Dis Med Microbiol. 2012. 23:e103–5.
Article
10). Konno T., Suzuki H., Kutsuzawa T., Imai A., Katsushima N., Sakamoto M, et al. Human rotavirus and intussusception. N Engl J Med. 1977. 297:945.
11). Takahashi S., Oki J., Miyamoto A., Koyano S., Ito K., Azuma H, et al. Encephalopathy associated with haemophagocytic lymphohistiocytosis following rotavirus infection. Eur J Pediatr. 1999. 158:133–7.
Article
12). Riepenhoff-Talty M., Gouvea V., Evans MJ., Svensson L., Hoffenberg E., Sokol RJ, et al. Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis. 1996. 174:8–15.
Article
13). Sanghai SR., Shah I., Bhatnagar S., Murthy A. Incidence and prognostic factors associated with biliary atresia in western India. Ann Hepatol. 2009. 8:120–2.
14). Ko JS., Seo JK. The etiologies of neonatal cholestasis. Korean J Pediatr. 2007. 50:835–40.
Article
15). Naini BV., Lassman CR. Total parenteral nutrition therapy and liver injury: a histopathologic study with clinical correlation. Hum Pathol. 2012. 43:826–33.
Article
16). Hertel PM., Estes MK. Rotavirus and biliary atresia: can causation be proven? Curr Opin Gastroenterol. 2012. 28:10–7.
17). Shivakumar P., Sabla GE., Whitington P., Chougnet CA., Bezerra JA. Neonatal NK cells target the mouse duct epithelium via Nkg2d and drive tissue-specific injury in experimental biliary atresia. J Clin Invest. 2009. 119:2281–90.
Article
18). St-Jules DE., Watters CA., Iwamoto LM. Use of fish oil-based lipid emulsions in infants with intestinal failure-associated liver disease: a case series. Infant Child Adolesc Nutr. 2014. 6:6–13.
19). Park HW., Lee NM., Kim JH., Kim KS., Kim SN. Parenteral fish oil-containing lipid emulsions may reverse parenteral nutrition-associated cholestasis in neonates: a systematic review and meta-analysis. J Nutr. 2015. 145:277–83.
Article
20). Shneider BL., Magee JC., Bezerra JA., Haber B., Karpen SJ., Raghunathan T, et al. Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia. Pediatrics. 2012. 130:e607–14.
Article